Overview

Use of Synvisc® in Knee Osteoarthritis - Survey on Practice

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study of prescription methods in everyday medical practice, tolerance profile and effect of Synvisc® until six months of follow-up.
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Hyaluronic Acid
Hylan